Laurent Roche
Overview
Explore the profile of Laurent Roche including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
34
Citations
239
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Multidimensional penalized splines for survival models: illustration for net survival trend analyses
Dantony E, Uhry Z, Fauvernier M, Coureau G, Mounier M, Tretarre B, et al.
Int J Epidemiol
. 2024 Mar;
53(2).
PMID: 38499394
Background: In descriptive epidemiology, there are strong similarities between incidence and survival analyses. Because of the success of multidimensional penalized splines (MPSs) in incidence analysis, we propose in this pedagogical...
2.
Galzin E, Roche L, Vlachomitrou A, Nempont O, Carolus H, Schmidt-Richberg A, et al.
Res Diagn Interv Imaging
. 2023 Jun;
4:100018.
PMID: 37284031
Objectives: We evaluated the contribution of lung lesion quantification on chest CT using a clinical Artificial Intelligence (AI) software in predicting death and intensive care units (ICU) admission for COVID-19...
3.
Atsou K, Rachet B, Cornet E, Chretien M, Rossi C, Remontet L, et al.
Cancer Med
. 2023 Jan;
12(7):8911-8923.
PMID: 36710405
Background: The excess mortality observed in Acute Myeloblastic Leukaemia (AML) patients, partly attributed to unequal access to curative treatments, could be linked to care pathways. Methods: We included 1039 AML...
4.
Dumontet C, Demangel D, Galia P, Karlin L, Roche L, Fauvernier M, et al.
Am J Hematol
. 2023 Jan;
98(2):264-271.
PMID: 36588407
Familial forms of monoclonal gammopathy, defined as multiple myeloma (MM) or Monoclonal Gammopathy of Undetermined Significance (MGUS), are relatively infrequent and most series reported in the literature describe a limited...
5.
Poiseuil M, Tron L, Woronoff A, Tretarre B, Dabakuyo-Yonli T, Fauvernier M, et al.
Int J Cancer
. 2021 Sep;
150(2):253-262.
PMID: 34520579
Several studies have investigated the association between net survival (NS) and social inequalities in people with cancer, highlighting a varying influence of deprivation depending on the type of cancer studied....
6.
Gasqui M, Perard M, Decup F, Monsarrat P, Turpin Y, Villat C, et al.
Oral Radiol
. 2021 May;
38(1):89-98.
PMID: 33954908
Background: During interventions for deep caries lesions without severe symptoms, preserving pulpal vitality is important to ensure treatment success, improve organ prognosis, and decrease cost-effectiveness. Current pre-operative radiographs allow visual...
7.
Nguyen K, Mimouni Y, Jaberi E, Paret N, Boussaha I, Vial T, et al.
Therapie
. 2021 Feb;
76(6):675-685.
PMID: 33593598
Introduction: To date, few studies have shown a significant association between off-label drug use and adverse drug reactions (ADRs). The main aims of this study is to evaluate the relationship...
8.
Gaillard S, Roche L, Lemoine S, Deschenes G, Morin D, Vianey-Saban C, et al.
Pediatr Nephrol
. 2020 Sep;
36(3):581-589.
PMID: 32901297
Introduction: In nephropathic cystinosis (NC), adherence to cysteamine remains challenging; poor adherence is worsening the disease progression with a decline of kidney function and increase of extrarenal morbidities. Our objective...
9.
Uhry Z, Chatignoux E, Dantony E, Colonna M, Roche L, Fauvernier M, et al.
Int J Epidemiol
. 2020 Aug;
49(4):1294-1306.
PMID: 32830255
Background: Cancer-incidence and mortality-trend analyses require appropriate statistical modelling. In countries without a nationwide cancer registry, an additional issue is estimating national incidence from local-registry data. The objectives of this...
10.
Gaillard S, Roche L, Deschenes G, Morin D, Vianey-Saban C, Acquaviva-Bourdain C, et al.
Therapie
. 2020 Apr;
75(2):169-173.
PMID: 32248985
Rare diseases usually concern small and disseminated population. Implementing clinical research with the right design, outcomes measures and the recruitment of patients are challenges. Collaborations, training and multidisciplinary approach are...